BCL2L11 and esophageal squamous cell carcinoma: In summary, our study revealed a previously unknown inhibitory efficacy of celastrol on ESCC by activating DR5-dependent extrinsic and Noxa/Bim-dependent intrinsic apoptosis, suggesting that celastrol was a candidate for apoptosis inducer in recalcitrant human ESCC.